BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10655355)

  • 21. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a real-time quantitative assay for detection of Epstein-Barr virus.
    Niesters HG; van Esser J; Fries E; Wolthers KC; Cornelissen J; Osterhaus AD
    J Clin Microbiol; 2000 Feb; 38(2):712-5. PubMed ID: 10655372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
    Peters AC; Akinwumi MS; Cervera C; Mabilangan C; Ghosh S; Lai R; Iafolla M; Doucette K; Preiksaitis JK
    Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A semiquantitative PCR method (SQ-PCR) to measure Epstein-Barr virus (EBV) load: its application in transplant patients.
    Fellner MD; Durand K; Correa M; Bes D; Alonio LV; Teyssié AR; Picconi MA
    J Clin Virol; 2003 Dec; 28(3):323-30. PubMed ID: 14522071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A; Nazzari C; Verzaro S; Latte MC; Fabri G; Scateni S; Raggi C; Lubrano R; Mancini C
    New Microbiol; 2006 Oct; 29(4):231-41. PubMed ID: 17201089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring.
    Preiksaitis J; Allen U; Bollard CM; Dharnidharka VR; Dulek DE; Green M; Martinez OM; Metes DM; Michaels MG; Smets F; Chinnock RE; Comoli P; Danziger-Isakov L; Dipchand AI; Esquivel CO; Ferry JA; Gross TG; Hayashi RJ; Höcker B; L'Huillier AG; Marks SD; Mazariegos GV; Squires J; Swerdlow SH; Trappe RU; Visner G; Webber SA; Wilkinson JD; Maecker-Kolhoff B
    Pediatr Transplant; 2024 Feb; 28(1):e14471. PubMed ID: 37294621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
    Weintraub L; Weiner C; Miloh T; Tomaino J; Joashi U; Benchimol C; Strauchen J; Roth M; Wistinghausen B
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Epstein-Barr virus DNA to monitor lymphoproliferative disease following pediatric liver transplantation.
    Gridelli B; Spada M; Riva S; Colledan M; Segalin A; Lucianetti A; Sonzogni A; Furione M; Baldanti F; Torre G
    Transpl Int; 2000; 13 Suppl 1():S399-401. PubMed ID: 11112041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.
    Sebelin-Wulf K; Nguyen TD; Oertel S; Papp-Vary M; Trappe RU; Schulzki A; Pezzutto A; Riess H; Subklewe M
    Transpl Immunol; 2007 Apr; 17(3):203-10. PubMed ID: 17331848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantation of solid organ recipients shedding Epstein-Barr virus DNA pre-transplant: A prospective study.
    Verghese PS; Schmeling DO; Filtz EA; Grimm JM; Matas AJ; Balfour HH
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28915342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients.
    Macedo C; Zeevi A; Bentlejewski C; Popescu I; Green M; Rowe D; Smith L; Webber S; Metes D
    Transplantation; 2009 Jul; 88(1):123-8. PubMed ID: 19584691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.
    Tsai DE; Nearey M; Hardy CL; Tomaszewski JE; Kotloff RM; Grossman RA; Olthoff KM; Stadtmauer EA; Porter DL; Schuster SJ; Luger SM; Hodinka RL
    Am J Transplant; 2002 Nov; 2(10):946-54. PubMed ID: 12482147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Epstein-Barr virus genomes in peripheral blood B cells from solid-organ transplant recipients by fluorescence in situ hybridization.
    Rose C; Green M; Webber S; Kingsley L; Day R; Watkins S; Reyes J; Rowe D
    J Clin Microbiol; 2002 Jul; 40(7):2533-44. PubMed ID: 12089275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus infection in adult renal transplant recipients.
    Morton M; Coupes B; Roberts SA; Johnson SL; Klapper PE; Vallely PJ; Picton ML
    Am J Transplant; 2014 Jul; 14(7):1619-29. PubMed ID: 24815922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and long-term outcomes of pediatric liver transplant recipients with chronic high Epstein-Barr virus loads.
    Kamei H; Ito Y; Kawada J; Ogiso S; Onishi Y; Komagome M; Kurata N; Ogura Y
    Transpl Infect Dis; 2018 Aug; 20(4):e12911. PubMed ID: 29677384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic testing in Epstein-Barr virus infection.
    Kudo T; Egawa H; Kuzushima K; Kimura H; Morishima T; Ichiyama S
    Clin Chem Lab Med; 2001 Sep; 39(9):789-94. PubMed ID: 11601674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation.
    Fukushima D; Sato K; Kawagishi N; Ohuchi N; Satomi S
    Transplantation; 2015 Jan; 99(1):114-9. PubMed ID: 24846306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients.
    Ishihara M; Tanaka E; Sato T; Chikamoto H; Hisano M; Akioka Y; Dohno S; Maeda A; Hattori M; Wakiguchi H; Fujieda M
    Clin Nephrol; 2011 Jul; 76(1):40-8. PubMed ID: 21722604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.